Essentials of nimodipine in neurocritical care patients

Authors

  • Sandra Marcela Mass-Ramirez
  • Carmen Sofia Sierra-Ochoa
  • Ivan David Lozada Marintez
  • Brayan Stiven Aristizabal-Carmona
  • Juan Esteban Suárez-Muñoz
  • Lina Marcela Ortiz-Roncallo University of La Sabana image/svg+xml
  • Jose David Rubiano-Buitrago
  • Bryan Hernández-Nieto
  • Sergio Antonio Barahona-Botache
  • Julián Eduardo Cárdenas-Mayorga
  • Luis Rafael Moscote-Salazar

DOI:

https://doi.org/10.33962/roneuro-2021-045

Keywords:

nimodipine, aneurysmal subarachnoid haemorrhage, cerebrovascular disorders, Central Nervous System Diseases, neuroprotection

Abstract

Nimodipine is a drug belonging to the group of calcium channel blockers, very well tolerated, widely recognized for its central action as a vasodilator preventing vasospasm secondary to aneurysmal subarachnoid haemorrhage. It is currently approved as a drug used in the treatment of this type of haemorrhage, mainly because it is effective in reducing neurological deficits due to delayed cerebral ischemia. In addition, due to its relaxing action on the cerebral vascular musculature and its facility to cross the blood-brain barrier, it has multiple functions in other types of cerebral vascular lesions such as ischemic stroke and other neurological conditions involving stress or cell death. Its role as a prophylactic agent in the treatment of migraine and its effect as a neuroprotective agent have also been evaluated.

Author Biographies

  • Sandra Marcela Mass-Ramirez

    Medical and Surgical Research Centre, University of Cartagena, Colombia

  • Carmen Sofia Sierra-Ochoa

    Medical and Surgical Research Centre, University of Cartagena, Colombia

  • Ivan David Lozada Marintez

    1 Medical and Surgical Research Centre, University of Cartagena, Colombia

    2 Colombian Clinical Research Group in Neurocritical Care, University of Cartagena, Colombia

    3 Latin American Council of Neurocritical Care, Cartagena, Colombia

    4 Global Neurosurgery Committee, World Federation of Neurosurgical Societies

  • Brayan Stiven Aristizabal-Carmona

    School of Medicine, Fundación Universitaria Autónoma de las Americas, Pereira, Colombia

  • Juan Esteban Suárez-Muñoz

    School of Medicine, Fundación Universitaria Autónoma de las Americas, Pereira, Colombia

  • Lina Marcela Ortiz-Roncallo, University of La Sabana

    School of Medicine, Universidad de La Sabana, Bogotá, Colombia

  • Jose David Rubiano-Buitrago

    School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia

  • Bryan Hernández-Nieto

    School of Medicine, Universidad Simón Bolivar, Barranquilla, Colombia

  • Sergio Antonio Barahona-Botache

    School of Medicine, Universidad Surcolombiana, Neiva, Colombia

  • Julián Eduardo Cárdenas-Mayorga

    School of Medicine, Fundación Universitaria Juan N Corpas, Bogotá, Colombia

  • Luis Rafael Moscote-Salazar

    1 Medical and Surgical Research Centre, University of Cartagena, Colombia

    2 Colombian Clinical Research Group in Neurocritical Care, University of Cartagena, Colombia

    3 Latin American Council of Neurocritical Care, Cartagena, Colombia

Downloads

Published

2021-09-15

How to Cite

Essentials of nimodipine in neurocritical care patients . (2021). Romanian Neurosurgery, 35(3), 270-276. https://doi.org/10.33962/roneuro-2021-045

Similar Articles

11-20 of 376

You may also start an advanced similarity search for this article.